LAWRENCE, Mass., Oct. 7, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that NxStage Kidney Care, Inc.'s first dialysis center has received Medicare certification from the Missouri Board of Health and is accepting new patients. NxStage Kidney Care was created from the ground up to support and encourage patient-centered care by providing enhanced access to the significant clinical and quality of life benefits possible with home based and more frequent dialysis, as prescribed. The first NxStage Kidney Care center is located in Des Peres, Missouri outside of St. Louis.
"At NxStage Kidney Care, we understand the need for more patient access to therapies beyond the thrice weekly in-center model," said Robert Brown, NxStage Kidney Care's President. "By leveraging the innovative technology of the NxStage® System One™, we're working to expand patient access to the life-changing benefits of home therapy as well as to flexible in-center options at the frequency and duration that works best for the patient. Our care model is designed to allow patients to take control of their dialysis and to allow physicians the flexibility to prescribe what is truly best for their patients."
"My life's work is providing dialysis patients with high quality care," stated Dr. Pablo Dayer, medical director of NxStage Kidney Care St. Louis. "This means listening to the patient, discussing care options, and letting the patient decide what works best for him/her. At NxStage Kidney Care, we work with the patient's physician and care team to develop the best therapy for each individual patient in terms of modality, location, frequency and duration. We are committed to expanding access to home and more frequent dialysis for prescribing physicians and their patients, when it is determined to be right for them, with the objective of improving clinical outcomes and helping our patients achieve a higher quality of life."
With 6,300 sq. ft located in the beautiful Des Peres area, the new NxStage Kidney Care St. Louis center provides a warm and comfortable setting with passionate, attentive staff members offering high levels of one-to-one service.
For St. Louis patients interested in learning more, please call 866-694-2707 or visit www.nxstagekidneycare.com for more information.
About NxStage Kidney Care NxStage Kidney Care Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to be truly life changing. NxStage Kidney Care was created from the ground up to support and encourage patient centered care by providing enhanced access to the significant clinical and quality of life benefits possible with home based and more frequent dialysis, as prescribed. By leveraging the innovative technology of the NxStage® System One™, NxStage Kidney Care is working to expand patient access to the life-changing benefits of home therapy as well as to flexible in-center options at the frequency and duration that works best for the patient. For more information, please visit www.nxstagekidneycare.com or call 866-694-2707 to learn more about the NxStage Kidney Care.
About the NxStage System One The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage Pureflow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, at home or on vacation. http://www.nxstage.com/.
About NxStage Medical NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
Forward-Looking Statements This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2013. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Kristen K. Sheppard, Esq. VP, Investor Relations firstname.lastname@example.org
SOURCE NxStage Medical, Inc.